Skip to main content

Table 2 Characteristics of patients with and without pemphigoid

From: Pemphigus and pemphigoid are associated with Alzheimer’s disease in older adults: evidence from the US Nationwide inpatient sample 2016–2018

Characteristics

Before matching

After matching

Total

(n = 7,036,932)

With pemphigoid

(n = 3265)

Without pemphigoid

(n = 7,033,667) a

p-value

Total

(n = 9474)

With pemphigoid

(n = 3158)

Without pemphigoid (n = 6316) a

p-value

AD

175,398 (2.5)

150 (4.6)

175,248 (2.5)

< 0.001

363 (3.8)

147 (4.7)

216 (3.4)

0.003

Age, years

73.9 ± 0.02

79.2 ± 0.16

73.9 ± 0.02

< 0.001

78.8 ± 0.1

79.2 ± 0.2

78.6 ± 0.1

0.003

 60–69

2,660,325 (37.8)

550 (16.9)

2,659,775 (37.8)

< 0.001

1584 (16.7)

528 (16.7)

1056 (16.7)

1.000

 70–79

2,311,346 (32.9)

978 (30.0)

2,310,368 (32.9)

 

2841 (30.0)

947 (30.0)

1894 (30.0)

 

 80+

2,065,261 (29.4)

1737 (53.2)

2,063,524 (29.3)

 

5049 (53.3)

1683 (53.3)

3366 (53.3)

 

Sex

   

0.680

   

1.000

 Male

3,296,330 (46.8)

1517 (46.5)

3,294,813 (46.8)

 

4392 (46.4)

1464 (46.4)

2928 (46.4)

 

 Female

3,740,602 (53.2)

1748 (53.5)

3,738,854 (53.2)

 

5082 (53.6)

1694 (53.6)

3388 (53.6)

 

Race

   

< 0.001

   

1.000

 White

5,201,334 (76.3)

2414 (76.4)

5,198,920 (76.3)

 

7242 (76.4)

2414 (76.4)

4828 (76.4)

 

 Black

728,794 (10.7)

345 (10.9)

728,449 (10.7)

 

1035 (10.9)

345 (10.9)

690 (10.9)

 

 Hispanic

530,265 (7.8)

163 (5.2)

530,102 (7.8)

 

489 (5.2)

163 (5.2)

326 (5.2)

 

 Others

356,555 (5.2)

236 (7.5)

356,319 (5.2)

 

708 (7.5)

236 (7.5)

472 (7.5)

 

 Missing

219,984

107

219,877

 

0

0

0

 

Household income

   

< 0.001

   

< 0.001

 Quartile1

1,942,868 (28.1)

692 (21.4)

1,942,176 (28.1)

 

2311 (24.7)

678 (21.7)

1633 (26.3)

 

 Quartile2

1,857,101 (26.8)

768 (23.8)

1,856,333 (26.8)

 

2386 (25.5)

727 (23.3)

1659 (26.7)

 

 Quartile3

1,685,094 (24.4)

824 (25.5)

1,684,270 (24.4)

 

2324 (24.9)

796 (25.5)

1528 (24.6)

 

 Quartile4

1,435,599 (20.7)

945 (29.3)

1,434,654 (20.7)

 

2318 (24.8)

921 (29.5)

1397 (22.5)

 

 Missing

116,270

36

116,234

 

135

36

99

 

Insurance status

   

< 0.001

   

< 0.001

 Medicare/Medicaid

5,780,220 (82.2)

2985 (91.5)

5,777,235 (82.2)

 

8498 (89.8)

2890 (91.6)

5608 (88.9)

 

 Private including HMO

1,016,463 (14.5)

212 (6.5)

1,016,251 (14.5)

 

780 (8.2)

206 (6.5)

574 (9.1)

 

 Self-pay/no-charge/other

232,166 (3.3)

65 (2.0)

232,101 (3.3)

 

189 (2.0)

60 (1.9)

129 (2.0)

 

 Missing

8083

3

8080

 

7

2

5

 

Active tobacco use

   

< 0.001

   

0.189

 No

4,430,321 (63.0)

2310 (70.8)

4,428,011 (63.0)

 

6355 (67.1)

2231 (70.6)

4124 (65.3)

 

 Yes

2,606,611 (37.0)

955 (29.3)

2,605,656 (37.1)

 

3119 (32.9)

927 (29.4)

2192 (34.7)

 

Excessive alcohol use

   

0.007

   

< 0.001

 No

6,786,718 (96.4)

3178 (97.3)

6,783,540 (96.4)

 

9255 (97.7)

3076 (97.4)

6179 (97.8)

 

 Yes

250,214 (3.6)

87 (2.7)

250,127 (3.6)

 

219 (2.3)

82 (2.6)

137 (2.2)

 

Chronic disease

        

 Ischemic heart disease

2,173,764 (30.9)

957 (29.3)

2,172,807 (30.9)

0.056

3049 (32.2)

936 (29.6)

2113 (33.5)

< 0.001

 Valvular heart disease

246,112 (3.5)

157 (4.8)

245,955 (3.5)

< 0.001

424 (4.5)

151 (4.8)

273 (4.3)

0.336

 DM

2,409,835 (34.3)

1434 (43.9)

2,408,401 (34.2)

< 0.001

3446 (36.4)

1385 (43.9)

2061 (32.6)

< 0.001

 Hypertension

5,284,662 (75.1)

2635 (80.7)

5,282,027 (75.1)

< 0.001

7429 (78.4)

2551 (80.8)

4878 (77.2)

< 0.001

 Dyslipidemia

3,233,028 (45.9)

1484 (45.5)

3,231,544 (45.9)

0.586

4400 (46.4)

1438 (45.5)

2962 (46.9)

0.214

 Obesity

1,201,438 (17.1)

709 (21.7)

1,200,729 (17.1)

< 0.001

1577 (16.6)

691 (21.9)

886 (14.0)

< 0.001

 Chronic pulmonary disease

2,051,952 (29.2)

951 (29.1)

2,051,001 (29.2)

0.968

2744 (29.0)

914 (28.9)

1830 (29.0)

0.975

 Severe liver disease

112,892 (1.6)

28 (0.9)

112,864 (1.6)

0.001

96 (1.0)

27 (0.9)

69 (1.1)

0.297

 Moderate to severe kidney disease

299,502 (4.3)

155 (4.8)

299,347 (4.3)

0.211

390 (4.1)

149 (4.7)

241 (3.8)

0.053

 Coagulopathy

518,045 (7.4)

306 (9.4)

517,739 (7.4)

< 0.001

790 (8.3)

294 (9.3)

496 (7.9)

0.017

 Peripheral vascular disease

726,601 (10.3)

356 (10.9)

726,245 (10.3)

0.289

1086 (11.5)

345 (10.9)

741 (11.7)

0.249

 Atrial fibrillation

1,699,223 (24.2)

1028 (31.4)

1,698,195 (24.1)

< 0.001

2935 (31.0)

993 (31.4)

1942 (30.7)

0.501

 Psychosis

105,599 (1.5)

44 (1.4)

105,555 (1.5)

0.481

110 (1.2)

43 (1.4)

67 (1.1)

0.201

 Depression

932,607 (13.3)

418 (12.8)

932,189 (13.3)

0.462

1121 (11.8)

403 (12.8)

718 (11.4)

0.053

Systemic autoimmune disease

        

 SLE

27,644 (0.4)

14 (0.4)

27,630 (0.4)

0.758

32 (0.3)

14 (0.4)

18 (0.3)

0.215

 RA

186,516 (2.7)

84 (2.6)

186,432 (2.7)

0.793

247 (2.6)

79 (2.5)

168 (2.7)

0.653

 IBD

61,701 (0.9)

23 (0.7)

61,678 (0.9)

0.311

76 (0.8)

23 (0.7)

53 (0.8)

0.581

 SSc

9273 (0.1)

3 (0.1)

9270 (0.1)

0.529

12 (0.1)

3 (0.1)

9 (0.1)

0.539

 Sjogren’s syndrome

15,770 (0.2)

12 (0.4)

15,758 (0.2)

0.108

24 (0.3)

12 (0.4)

12 (0.2)

0.090

Other chronic inflammatory skin disease

        

 Atopic dermatitis

1361 (0.02)

3 (0.09)

1358 (0.02)

0.003

3 (0.0)

3 (0.1)

0 (0.0)

 

 Hidradenitis

1572 (0.02)

1 (0.03)

1571 (0.02)

0.751

4 (0.0)

1 (0.0)

3 (0.0)

0.722

 Dermatomyositis & polymyositis

3652 (0.1)

3 (0.1)

3649 (0.1)

0.316

7 (0.1)

3 (0.1)

4 (0.1)

0.592

 Psoriasis

43,873 (0.6)

63 (1.9)

43,810 (0.6)

< 0.001

96 (1.0)

59 (1.9)

37 (0.6)

< 0.001

 Alopecia areata

134 (0.00)

1 (0.03)

133 (0.00)

< 0.001

1 (0.0)

1 (0.0)

0 (0.0)

 

 Vitiligo

1817 (0.03)

2 (0.06)

1815 (0.03)

0.208

2 (0.0)

2 (0.1)

0 (0.0)

 

 Pyoderma gangrenosum

1274 (0.02)

4 (0.12)

1270 (0.02)

< 0.001

4 (0.0)

4 (0.1)

0 (0.0)

 

 Rosacea

6642 (0.1)

4 (0.1)

6638 (0.1)

0.600

7 (0.1)

4 (0.1)

3 (0.0)

0.181

Hospital bed size

   

0.183

   

0.119

 Large

3,416,691 (48.6)

1631 (50.0)

3,415,060 (48.6)

 

4568 (48.2)

1567 (49.6)

3001 (47.5)

 

 Medium

2,083,915 (29.6)

916 (28.1)

2,082,999 (29.6)

 

2792 (29.5)

890 (28.2)

1902 (30.1)

 

 Small

1,536,326 (21.8)

718 (22.0)

1,535,608 (21.8)

 

2114 (22.3)

701 (22.2)

1413 (22.4)

 

Hospital location/teaching status

   

< 0.001

   

< 0.001

 Urban teaching

4,516,510 (64.2)

2357 (72.2)

4,514,153 (64.2)

 

6248 (65.9)

2275 (72.0)

3973 (62.9)

 

 Urban nonteaching

1,769,201 (25.1)

652 (20.0)

1,768,549 (25.1)

 

2265 (23.9)

640 (20.3)

1625 (25.7)

 

 Rural

751,221 (10.7)

256 (7.8)

750,965 (10.7)

 

961 (10.1)

243 (7.7)

718 (11.4)

 

Hospital region

   

< 0.001

   

< 0.001

 Northeast

1,383,999 (19.7)

905 (27.7)

1,383,094 (19.7)

 

2272 (24.0)

891 (28.2)

1381 (21.9)

 

 Midwest

1,582,288 (22.5)

801 (24.5)

1,581,487 (22.5)

 

2114 (22.3)

747 (23.7)

1367 (21.6)

 

 South

2,758,422 (39.2)

916 (28.1)

2,757,506 (39.2)

 

3306 (34.9)

900 (28.5)

2406 (38.1)

 

 West

1,312,223 (18.7)

643 (19.7)

1,311,580 (18.7)

 

1782 (18.8)

620 (19.6)

1162 (18.4)

 
  1. All significant values are shown in bold
  2. Abbreviation: AD Alzheimer’s disease, DM diabetes mellitus, SLE systemic lupus erythematosus, RA rheumatoid arthritis, IBD inflammatory bowel disease, SSc systemic sclerosis
  3. aExcluded pemphigus